The stock markets in the US opened higher on February 4 as investors remained cautious about China’s stance on the Trump tariffs. Salesforce shares were trading 1.64% higher in the early market ...

The S&P 500 Index ($SPX) (SPY) today is up +0.58%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.09%, and the Nasdaq ...

We recently compiled a list of the 12 Best S&P 500 Stocks to Invest in According to Analysts. In this article, we are going ...

We recently published a list of 10 Best Stocks to Buy and Hold For 2025. In this article, we are going to take a look at ...

Your biospecimen will be sent to the Regeneron Genetics Center for genetic sequencing, then stored for future analysis. With something as sacred as your genetic material in its hands, Truveta and ...

The Trump-Vance Transition Team unveiled on Thursday the administration's official portraits of President-elect Donald Trump and Vice President-elect JD Vance. "In just four days, Donald J.

The President-elect Trump who will take the oath of office Monday is a radically different figure from the one who shook up Washington eight years ago. This Trump knows more about how Washington ...

This combination of images shows a man holding a smartphone displaying the logo of Chinese social media platform TikTok in Paris last year, as well as President-elect Donald Trump in May.

President-elect Donald Trump will unleash an onslaught of actions immediately after taking command at the White House on Monday, including sealing the southern border, barring transgender people ...

President-elect Donald Trump said the U.S. government would no longer subsidize new windmill farms and reiterated his stance that he doesn’t “want even one built” during his administration ...

Despite it being President-elect Donald Trump's return to Washington, D.C., many will be focused on a younger Trump: 18-year-old son Barron. The internet went wild for the New York University ...

Regeneron stock has trended bearishly since August, but growth in LIBTAYO and DUPIXENT offers a promising outlook, prompting a BUY rating. EYLEA HD's success mitigates biosimilar competition ...